MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, S.
Right arrow Articles by Mazella, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, S.
Right arrow Articles by Mazella, J.

Vol. 55, Issue 2, 210-215, February 1999

Pivotal Role of an Aspartate Residue in Sodium Sensitivity and Coupling to G Proteins of Neurotensin Receptors

Stéphane Martin, Jean-Marie Botto, Jean-Pierre Vincent, and Jean Mazella

Institut de Pharmacologie Moléculaire et Cellulaire, Unité Propre de Recherche 411, Centre National de la Recherche Scientifique, Valbonne, France

The highly conserved aspartate residue in the second transmembrane domain of G protein-coupled receptors is present in position 113 in the type 1 neurotensin receptor (NTR1) but is replaced by an Ala residue in position 79 in the type 2 neurotensin receptor (NTR2). NTR1 couples to Galpha q to stimulate phospholipase C and its binding affinity for neurotensin is decreased by sodium ions and GTP analogs. By contrast, NTR2 does not seem to couple to any G protein in eukaryotic cells, and its binding of neurotensin is insensitive to sodium and GTP analogs. By using site-directed mutagenesis, we substituted Asp113 of the NTR1 by alanine and the homologous residue Ala79 of NTR2 by aspartate. Both mutant receptors display similar affinity for neurotensin as compared with their respective wild type. We demonstrate that the presence of the Asp residue determines by itself the occurrence of the sodium effect on neurotensin affinity for both wild-type and mutated NTR1 and -2. The introduction of an Asp in the second transmembrane domain of NTR2 is not enough to restore a functional coupling to G proteins. In contrast, replacement of Asp113 by Ala residue in NTR1 strongly decreases its ability to activate inositol turnover, indicating that the functionally active conformation of NTR1 is maintained by interaction of sodium ions with aspartate 113.

Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
L. Oliveira, C. M. Costa-Neto, C. R. Nakaie, S. Schreier, S. I. Shimuta, and A. C. M. Paiva
The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure
Physiol Rev, April 1, 2007; 87(2): 565 - 592.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
J H Li, F Sicard, M A Salam, M Baek, J LePrince, H Vaudry, K Kim, H B Kwon, and J Y Seong
Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain
J. Mol. Endocrinol., June 1, 2005; 34(3): 793 - 807.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
F. St-Gelais, M. Legault, M.-J. Bourque, P.-P. Rompre, and L.-E. Trudeau
Role of Calcium in Neurotensin-Evoked Enhancement in Firing in Mesencephalic Dopamine Neurons
J. Neurosci., March 10, 2004; 24(10): 2566 - 2574.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Luca, J. F. White, A. K. Sohal, D. V. Filippov, J. H. van Boom, R. Grisshammer, and M. Baldus
The conformation of neurotensin bound to its G protein-coupled receptor
PNAS, September 16, 2003; 100(19): 10706 - 10711.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Z.-G. Gao, S.-K. Kim, A. S. Gross, A. Chen, J. B. Blaustein, and K. A. Jacobson
Identification of Essential Residues Involved in the Allosteric Modulation of the Human A3 Adenosine Receptor
Mol. Pharmacol., May 1, 2003; 63(5): 1021 - 1031.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Okada, Y. Fujiyoshi, M. Silow, J. Navarro, E. M. Landau, and Y. Shichida
Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography
PNAS, April 30, 2002; 99(9): 5982 - 5987.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
F. Richard, S. Barroso, J. Martinez, C. Labbe-Jullie, and P. Kitabgi
Agonism, Inverse Agonism, and Neutral Antagonism at the Constitutively Active Human Neurotensin Receptor 2
Mol. Pharmacol., December 1, 2001; 60(6): 1392 - 1398.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. A. Neve, M. G. Cumbay, K. R. Thompson, R. Yang, D. C. Buck, V. J. Watts, C. J. DuRand, and M. M. Teeter
Modeling and Mutational Analysis of a Putative Sodium-Binding Pocket on the Dopamine D2 Receptor
Mol. Pharmacol., August 1, 2001; 60(2): 373 - 381.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Okada, Y. Fujiyoshi, M. Silow, J. Navarro, E. M. Landau, and Y. Shichida
Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography
PNAS, April 30, 2002; 99(9): 5982 - 5987.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics